Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sagredo

Showing results (1-10 of 2) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|September 11, 2008
The endocannabinoid system in Huntington's diseaseM R Pazos, O Sagredo, J Fernández-Ruiz
Cell Death & Disease|October 19, 2013
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AGS Valdeolivas, M R Pazos, T Bisogno, et al.
Pageof 1

Showing results (1-10 of 2) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|September 11, 2008
The endocannabinoid system in Huntington's diseaseM R Pazos, O Sagredo, J Fernández-Ruiz
Cell Death & Disease|October 19, 2013
The inhibition of 2-arachidonoyl-glycerol (2-AG) biosynthesis, rather than enhancing striatal damage, protects striatal neurons from malonate-induced death: a potential role of cyclooxygenase-2-dependent metabolism of 2-AGS Valdeolivas, M R Pazos, T Bisogno, et al.
Pageof 1